Reduced gene expression of bikunin as a prognostic marker for renal cell carcinoma

Experimental Oncology

Volumn 36, Issue 2, 2014, Pages 107-111

  Bayraktar, E ^a   Igci, M ^a   Erturhan, S ^a   Igci, Y Z ^a   Karakok, M ^a   Gogebakan, B ^b   Ulasli, M ^a   Cakmak, E A ^a   Arslan, A ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Bikunin; Nucleotide sequence analysis; Prognostic marker; Renal cell carcinoma; Semi quantitative RT PCR

Indexed keywords

DNA; MESSENGER RNA; RNA; ULINASTATIN; ALPHA GLOBULIN; ALPHA-1-MICROGLOBULIN; TUMOR MARKER;

ADULT; ARTICLE; CANCER PROGNOSIS; CLINICAL ARTICLE; DNA EXTRACTION; FEMALE; GENE CONSTRUCT; GENE EXPRESSION; GENE MUTATION; HUMAN; KIDNEY CARCINOMA; MALE; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA EXTRACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; AGED; CANCER STAGING; CARCINOMA, RENAL CELL; EXON; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; KIDNEY NEOPLASMS; METASTASIS; MIDDLE AGED; MORTALITY; MUTATION; PROGNOSIS; RISK FACTOR; TUMOR VOLUME;

ADULT; AGED; ALPHA-GLOBULINS; CARCINOMA, RENAL CELL; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84903762324     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Kiyama R, Zhu Y, Aoyagi T. Genetics of renal tumors. In: Renal Tumor. J Chen, Ed. Tokyo: Intech, 2013.
2. Yin-Goen Q, Dale J, Yang WL, et al. Advances in molecular classification of renal neoplasms. Histol Histopathol 2006; 21: 325-39. (Pubitemid 43033741)
3. Kobayashi H, Suzuki K, Sugino D, et al. Urinary trypsin inhibitor levels in amniotic fluid of normal human pregnancy: decreased levels observed at parturition. Am J Obstet Gynecol 1999; 180: 141-7. (Pubitemid 29088404)
4. Pugia MJ, Valdes R Jr, Jortani SA. Bikunin (urinary trypsin inhibitor): structure, biological relevance, and measurement. Adv Clin Chem 2007; 44: 223-45.
5. Salier JP, Chan P, Raguenez G, et al. Developmentally regulated transcription of the four liver-specific genes for inter-alpha-inhibitor family in mouse. Biochem J 1993; 296: 85-91. (Pubitemid 23344733)
6. Itoh H, Tomita M, Kobayashi T, et al . Expression of Inter-alpha-trypsin inhibitor light chain (bikunin) in human pancreas. J Biochem 1996; 120: 271-5. (Pubitemid 26335918)
7. Daveau M, Jean L, Soury E, et al. Hepatic and extrahepatic transcription of inter-alpha-inhibitor family genes under normal or acute inflammatory conditions in rat. Arch Biochem Biophys 1998; 350: 315-23. (Pubitemid 28368659)
8. Businaro R, Leali FM, De Renzis G, et al. Inter-alphatrypsin inhibitor-related immunoreactivity in human tissues and body fluids. Cell Mol Biol 1992; 38: 463-71.
9. Shikimi T, Hattori K, Takaori S. Existence of a human urinary trypsin inhibitor (urinastatin)-like substance in the rat brain. Jpn J Pharmacol 1992; 60: 97-103.
10. Yoshida E, Sumi H, Maruyama M, et al. Distribution of acid stable trypsin inhibitor immunoreactivity in normal and malignant human tissues. Cancer 1989; 64: 860-9. (Pubitemid 19188826)
11. Fries E, Blom AM. Bikunin - not just a plasma proteinase inhibitor. Int J Biochem Cell Biol 2000; 32: 125-37. (Pubitemid 30001817)
12. Shigetomi H, Onogi A, Kajiwara H, et al. Anti-inflammatory actions of serine protease inhibitors containing the Kunitz domain. Inflamm Res 2010; 59: 679-87.
13. Reuning U, Magdolen V, Wilhelm O, et al . Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review). Int J Oncol 1998; 13: 893-906. (Pubitemid 28506055)
14. Suzuki M, Kobayashi H, Tanaka Y, et al. Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin. Int J Cancer 2003; 104: 289-302. (Pubitemid 36249811)
15. Kobayashi H. Suppression of urokinase expression and tumor metastasis by bikunin overexpression [mini-review]. Hum Cell 2001; 14: 233-6.
16. Kobayashi H, Fujie M, Shinohara H, et al . Effects of urinary trypsin inhibitor on the invasion of reconstituted basement membranes by ovarian cancer cells. Int J Cancer 1994; 57: 378-84. (Pubitemid 24168613)
17. Kobayashi H, Suzuki M, Kanayama N, et al. Suppression of urokinase receptor expression by bikunin is associated with inhibition of upstream targets of extracellular signal-regulated kinase-dependent cascade. Eur J Biochem 2002; 269: 3945-57. (Pubitemid 34994889)
18. Kobayashi H, Suzuki M, Tanaka Y, et al. Suppression of urokinase expression and invasiveness by urinary trypsin inhibitor is mediated through inhibition of protein kinase C- and MEK/ERK/c-Jun-dependent signaling pathways. J Biol Chem 2001; 276: 2015-22. (Pubitemid 32109681)
19. Amin MB, Amin MB, Tamboli P, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 2002; 26: 281-91. (Pubitemid 34184451)
20. Truong LD, Shen SS. Immunohistochemical diagnosis of renal neoplasms. Arch Pathol Lab Med 2011; 135: 92-109.
21. Kobayashi H, Suzuki M, Hirashima Y, et al. The protease inhibitor bikunin, a novel anti-metastatic agent. Biol Chem 2003; 384: 749-54. (Pubitemid 36747936)
22. Delaria KA, Muller DK, Marlor CW, et al. Characterization of placental bikunin, a novel human serine protease inhibitor. J Biol Chem 1997; 272: 12209-14. (Pubitemid 27202806)
23. Wilharm E, Parry MA, Friebel R, et al. Generation of catalytically active granzyme K from Escherichia coli inclusion bodies and identification of efficient granzyme K inhibitors in human plasma. J Biol Chem 1999; 274: 27331-7.
24. Baker MS, Bleakley P, Woodrow GC, et al. Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation. Cancer Res 1990; 50: 4676-84. (Pubitemid 20230412)
25. Duffy MJ. The urokinase plasminogen activator system: role in malignancy. Curr Pharm Des 2004; 10: 39-49. (Pubitemid 38072742)
26. Danø K, Behrendt N, Høyer-Hansen G, et al. Plasminogen activation and cancer. Thromb Haemost 2005; 93: 676-81. (Pubitemid 40485402)
27. Price JT, Bonovich MT, Kohn EC. The biochemistry of cancer dissemination. Crit Rev Biochem Mol Biol 1997; 32: 175-253. (Pubitemid 27305153)
28. Blood CH, Zetter BR. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1990; 1032: 89-118.
29. Duffy MJ. The biochemistry of metastasis. Adv Clin Chem 1996; 32: 135-66.
30. Brown PD. Clinical studies with matrix metalloproteinase inhibitors. APMIS 1999; 107: 174-80. (Pubitemid 29133538)
31. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006; 25: 9-34. (Pubitemid 43723979)
32. Brooks SA, Lomax-Browne HJ, Carter TM, et al. Molecular interactions in cancer cell metastasis. Acta Histochem 2010; 112: 3-25.
33. Suzuki M, Kobayashi H, Tanaka Y, et al. Bikunin target genes in ovarian cancer cells identified by microarray analysis. J Biol Chem 2003; 278: 14640-6. (Pubitemid 36799786)
34. Kobayashi H, Suzuki M, Kanayama N, et al. Genetic down-regulation of phosphoinositide 3-kinase by bikunin correlates with suppression of invasion and metastasis in human ovarian cancer HRA cells. J Biol Chem 2004; 279: 6371-9. (Pubitemid 38248770)
35. Hamm A, Veeck J, Bektas N, et al. Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis. BMC Cancer 2008; 8: 25.
36. Igci M, Arslan A, Igci YZ, et al. Bikunin and alpha1-microglobulin/ bikunin precursor (AMBP) gene mutational screening in patients with kidney stones: a case-control study. Scand J Urol Nephrol 2010; 44: 413-9.
37. Pugia MJ, Lott JA. Pathophysiology and diagnostic value of urinary trypsin inhibitors. Clin Chem Lab Med 2005; 43: 1-16. (Pubitemid 40287494)
38. Gou XH, Liu YY, Chen QL, et al. High level expression of bikunin in Pichia pastoris by fusion of human serum albumin. AMB Express 2012; 2: 14.
39. Yano T, Anraku S, Nakayama R, Ushijima K. Neuroprotective effect of urinary trypsin inhibitor against focal cerebral ischemia-reperfusion injury in rats. Anesthesiology 2003; 98: 465-73. (Pubitemid 36592816)
40. Xia Q, Yuan L, Yang XN, et al. Comparison of integrated Chinese and Western medicine with and without somatostatin supplement in the treatment of severe acute pancreatitis. World J Gastroenterol 2005; 11: 1073-6. (Pubitemid 40347768)
41. O'Seaghdha CM, Hwang SJ, Larson MG, et al. Analysis of a urinary biomarker panel for incident kidney disease and clinical outcomes. J Am Soc Nephrol 2013; 24: 1880-8.
42. Pierzchalski P, Rokita H, Koj A, et al. Synthesis of alpha 1-microglobulin in cultured rat hepatocytes is stimulated by interleukin-6, leukemia inhibitory factor, dexamethasone and retinoic acid. FEBS Lett 1992; 298: 165-8.
43. Médétognon-Benissan J, Tardivel S, Hennequin C, et al. Inhibitory effect of bikunin on calcium oxalate crystallization in vitro and urinary bikunin decrease in renal stone formers. Urol Res 1999; 27: 69-75. (Pubitemid 29145093)